Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edith A Perez

Showing results (1-10 of 324) with videos related to

Pageof 33
Sort By:
Molecular Cancer Therapeutics|August 13, 2009
Microtubule inhibitors: Differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistanceEdith A Perez
Clinical Advances in Hematology & Oncology : H&O|March 19, 2014
Practice-changing data in metastatic breast cancerEdith A Perez
Clinical Breast Cancer|February 3, 2004
Gemcitabine and platinum combinations in patients with breast cancer previously treated with anthracyclines and/or taxanesEdith A Perez
Current Oncology Reports|December 11, 2003
Letrozole in postmenopausal women after five years on tamoxifenEdith A Perez
Breast (Edinburgh, Scotland)|June 5, 2004
Cardiac issues related to trastuzumabEdith A Perez
Idrugs : the Investigational Drugs Journal|November 25, 2004
Anti-cancer treatment - 12th International Congress. 4-7 February 2002, Paris, FranceEdith A Perez
Breast Cancer Research and Treatment|April 30, 2008
Impact, mechanisms, and novel chemotherapy strategies for overcoming resistance to anthracyclines and taxanes in metastatic breast cancerEdith A Perez
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 3, 2016
Treatment strategies for advanced hormone receptor-positive and human epidermal growth factor 2-negative breast cancer: the role of treatment orderEdith A Perez
Clinical Advances in Hematology & Oncology : H&O|October 17, 2014
Highlights in breast cancer from the 2014 American Society of Clinical Oncology® annual meetingEdith A Perez
Breast Disease|February 3, 2005
Management recommendations for adjuvant systemic breast cancer therapyEdith A Perez
Pageof 33

Showing results (1-10 of 324) with videos related to

Sort By:
Pageof 33
Molecular Cancer Therapeutics|August 13, 2009
Microtubule inhibitors: Differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistanceEdith A Perez
Clinical Advances in Hematology & Oncology : H&O|March 19, 2014
Practice-changing data in metastatic breast cancerEdith A Perez
Clinical Breast Cancer|February 3, 2004
Gemcitabine and platinum combinations in patients with breast cancer previously treated with anthracyclines and/or taxanesEdith A Perez
Current Oncology Reports|December 11, 2003
Letrozole in postmenopausal women after five years on tamoxifenEdith A Perez
Breast (Edinburgh, Scotland)|June 5, 2004
Cardiac issues related to trastuzumabEdith A Perez
Idrugs : the Investigational Drugs Journal|November 25, 2004
Anti-cancer treatment - 12th International Congress. 4-7 February 2002, Paris, FranceEdith A Perez
Breast Cancer Research and Treatment|April 30, 2008
Impact, mechanisms, and novel chemotherapy strategies for overcoming resistance to anthracyclines and taxanes in metastatic breast cancerEdith A Perez
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 3, 2016
Treatment strategies for advanced hormone receptor-positive and human epidermal growth factor 2-negative breast cancer: the role of treatment orderEdith A Perez
Clinical Advances in Hematology & Oncology : H&O|October 17, 2014
Highlights in breast cancer from the 2014 American Society of Clinical Oncology® annual meetingEdith A Perez
Breast Disease|February 3, 2005
Management recommendations for adjuvant systemic breast cancer therapyEdith A Perez
Pageof 33